Presentation2_The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review an... by Jinquan Gao (16752399)

“…The pooled results demonstrated that patients in the SV group showed significantly better efficacy representing as increased LVEF [weighted mean difference (WMD): 4.43%, 95% confidence interval (CI): 2.84%–6.02%, p < 0.001] and 6MWT (WMD: 30.84 m, 95% CI: 25.65 m–36.03 m, p < 0.001) and decreased LVEDD (WMD: −3.24 mm, 95% CI: −4.96 mm ∼ -1.52 mm, p < 0.001) and NT-proBNP (WMD: −188.12 pg/mL, 95% CI: −246.75 pg/mL ∼ 129.49 pg/mL, p < 0.001), which was also verified by subgroup analysis based on the history of percutaneous coronary intervention (PCI). …”

Table 1_Association of brain-derived neurotrophic factor in blood and cerebrospinal fluid with Parkinson’s disease and non-motor symptoms of Parkinson’s disease: a systematic revie... by Zhenzhen Zhao (782550)

“…The quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS). Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using Stata version 14.0, applying either a fixed-effect or a random-effects model based on heterogeneity. …”

Image_2_Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a S... by Jing Yang (13969)

“…Half of the patients eventually progressed to ESRD at a mean time of (13.04 ± 15.83) months after diagnosis. …”

Image_1_Clinical and Renal Histology Findings and Different Responses to Induction Treatment Affecting the Long-Term Renal Outcomes of Children With ANCA-Associated Vasculitis: a S... by Jing Yang (13969)

“…Half of the patients eventually progressed to ESRD at a mean time of (13.04 ± 15.83) months after diagnosis. …”

Presentation1_The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review an... by Jinquan Gao (16752399)

“…The pooled results demonstrated that patients in the SV group showed significantly better efficacy representing as increased LVEF [weighted mean difference (WMD): 4.43%, 95% confidence interval (CI): 2.84%–6.02%, p < 0.001] and 6MWT (WMD: 30.84 m, 95% CI: 25.65 m–36.03 m, p < 0.001) and decreased LVEDD (WMD: −3.24 mm, 95% CI: −4.96 mm ∼ -1.52 mm, p < 0.001) and NT-proBNP (WMD: −188.12 pg/mL, 95% CI: −246.75 pg/mL ∼ 129.49 pg/mL, p < 0.001), which was also verified by subgroup analysis based on the history of percutaneous coronary intervention (PCI). …”

Table 1_Biomechanical mechanisms of multidirectional dynamic compensatory muscle fatigue induced by abnormal cervical curvature: a cross-sectional case-control study based on surfa... by Rui Yang (293531)

“…Introduction<p>Cervical lordosis, a core indicator of spinal sagittal balance, is closely associated with cervical dysfunction when abnormal (straightening or kyphosis). …”

Supplementary video showing sidewinding by the studied viper from Snakes on a slope: strong anti-gravitactic responses and differential habitat use in the Saharan horned viper (<i>... by Arik Dorfman (12907989)

Risk of upper gastrointestinal bleeding with low-dose aspirin: case–control studies and cohort studies. by Luis A. García Rodríguez (594336)

“…^aData for duodenal bleeding and gastric bleeding (defined as bleeds located in the upper gastrointestinal tract, at sites other than the duodenum) [≤ 250 and 251–325 mg per day]; ^bData for plain, enteric-coated, and buffered aspirin; ^cData for different alcohol consumption categories (current drinker/never drinker/ex-drinker); ^dData for gastric ulcer and duodenal ulcer bleeding (defined as the presence of melena, haematemesis or haematochezia with a substantial decrease in haemoglobin and a peptic ulcer identified endoscopically); ^eData for primary and secondary prevention; ^fRisk of erosive esophagitis; ^gAcute defined as regular or sporadic aspirin use for 5–30 days before endoscopy; ^hChronic defined as regular aspirin use for more than 1 month before endoscopy; ⁱOR; ^jRR; ^kSIR; ^lHR. …”

Differential isoform ratios in FGFR3. by David O. Holland (12542869)

Image2_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

“…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”

Image1_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

“…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”

Table1_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

“…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”

Table2_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

“…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”

Pathologic assessment of tyrosine hydroxylase-stained sections of striatum in different studied groups highlighting positive dopaminergic terminal in each group. by Nehal Shawky Nagy (17721213)

Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca²⁺]i overload and NF-κB activation by Nadia A. Rivero-Segura (4006709)

DataSheet1_Combing mechanical side-deep fertilization and controlled-release nitrogen fertilizer to increase nitrogen use efficiency by reducing ammonia volatilization in a double... by Zhaoming Chen (2615245)

“…Rice grain yields in the MRSF with CRF treatments increased by 3.9–17.3% in early rice and 5.4–21.6% in late rice relative to the CFB treatment. …”

Variables of the simplified circulation model. by Shiro Kato (2444047)

“…From this concept, we can define another elastance determined by the slope of isochronous <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points, that is <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points at a certain time after the ejection onset time by using different loads. …”

Parameters in Eq (23). by Shiro Kato (2444047)

“…From this concept, we can define another elastance determined by the slope of isochronous <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points, that is <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points at a certain time after the ejection onset time by using different loads. …”

Circulation model. by Shiro Kato (2444047)

“…From this concept, we can define another elastance determined by the slope of isochronous <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points, that is <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points at a certain time after the ejection onset time by using different loads. …”

Contains C program code of the model. by Shiro Kato (2444047)

“…From this concept, we can define another elastance determined by the slope of isochronous <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points, that is <i>P</i>_<i>lv</i>—<i>V</i>_<i>lv</i> points at a certain time after the ejection onset time by using different loads. …”